KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,429,842 | -39.5% | 5,858,262 | 0.0% | 12.61% | -24.8% |
| Q2 2023 | $134,681,443 | -22.4% | 5,858,262 | 0.0% | 16.76% | -28.7% |
| Q1 2023 | $173,580,303 | +16.2% | 5,858,262 | -2.1% | 23.50% | +30.6% |
| Q4 2022 | $149,379,011 | -0.2% | 5,984,736 | -13.0% | 17.99% | +8.9% |
| Q3 2022 | $149,684,000 | +10.6% | 6,875,698 | 0.0% | 16.52% | -27.0% |
| Q2 2022 | $135,382,000 | -53.5% | 6,875,698 | 0.0% | 22.63% | -38.5% |
| Q1 2022 | $290,980,000 | -33.3% | 6,875,698 | 0.0% | 36.79% | -8.3% |
| Q4 2021 | $436,538,000 | – | 6,875,698 | – | 40.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |